doi: 10.2105/ajph.85.8_pt_1.1128.
Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women
Affiliations
- PMID: 7625511
- PMCID: PMC1615815
- DOI: 10.2105/ajph.85.8_pt_1.1128
Item in Clipboard
Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women
Am J Public Health.
1995 Aug.
Abstract
We assessed the association of hormonal replacement therapy with mortality and incidence of multiple diseases in over 40,000 postmenopausal women followed for 6 years as part of the Iowa Women's Health Study. Compared with women who never used hormone replacement therapy, current users had multivariate adjusted relative risks (RR) as follows: total mortality (RR = 0.78; 95% confidence interval [CI] = 0.65, 0.94), coronary heart disease mortality (RR = 0.74; 95% CI = 0.48, 1.12), endometrial cancer incidence (RR = 4.3; 95% CI = 2.7, 6.9), breast cancer incidence (RR = 1.23; 95% CI = 0.99, 1.55), colon cancer incidence (RR = 0.72; 95% CI = 0.46, 1.12), and hip fracture incidence (RR = 0.53; 95% CI = 0.31, 0.91).
Similar articles
-
Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).Lancet. 1998 Dec 19-26;352(9145):1965-9. doi: 10.1016/S0140-6736(98)05066-1. Lancet. 1998. PMID: 9872245
-
Adherence to the AICR cancer prevention recommendations and subsequent morbidity and mortality in the Iowa Women's Health Study cohort.Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1114-20. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15247121
-
Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women.JAMA. 2004 May 12;291(18):2212-20. doi: 10.1001/jama.291.18.2212. JAMA. 2004. PMID: 15138243
-
Where are we with postmenopausal hormone therapy in 2005?Gynecol Endocrinol. 2005 Nov;21(5):248-56. doi: 10.1080/09513590500279733. Gynecol Endocrinol. 2005. PMID: 16373243 Review.
-
Indications for hormone therapy: the post-Women's Health Initiative era.Endocrinol Metab Clin North Am. 2004 Dec;33(4):691-715. doi: 10.1016/j.ecl.2004.07.008. Endocrinol Metab Clin North Am. 2004. PMID: 15501641 Review.
Cited by
-
Menopausal hormone therapy use and risk of invasive colon cancer: the California Teachers Study.Am J Epidemiol. 2010 Feb 15;171(4):415-25. doi: 10.1093/aje/kwp434. Epub 2010 Jan 11. Am J Epidemiol. 2010. PMID: 20067917 Free PMC article.
-
Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the Iowa Women's Health Study.Ann Rheum Dis. 2002 Nov;61(11):994-9. doi: 10.1136/ard.61.11.994. Ann Rheum Dis. 2002. PMID: 12379522 Free PMC article.
-
The effects of transdermal and oral oestrogen replacement therapy on colorectal cancer risk in postmenopausal women.Br J Cancer. 2004 Jan 12;90(1):76-81. doi: 10.1038/sj.bjc.6601438. Br J Cancer. 2004. PMID: 14710210 Free PMC article.
-
Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer.Br J Cancer. 1996 Jun;73(11):1431-5. doi: 10.1038/bjc.1996.272. Br J Cancer. 1996. PMID: 8645593 Free PMC article.
-
Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).J Cardiovasc Transl Res. 2009 Sep;2(3):228-39. doi: 10.1007/s12265-009-9104-y. Epub 2009 May 22. J Cardiovasc Transl Res. 2009. PMID: 19668346 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
